https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015395.pub3&doi=10.1002/14651858.CD015395.pub3&type=cdsr&contentLanguage=&highlightAbstract=paxlovid
Lots of criticism levelled at Starpharma for not conducting human placebo trials. But in January we got a great significant human covid treatment trial. I think this report by Cochrane Org about Paxlovid changes perspective and one really questions how TGA meekly followed FDA and gave TA temporary approval to Pfizer. Cochrane seems very unimpressed
https://www.cochranelibrary.com/web/cochrane/content?templateType...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $13.48K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 124910 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 192818 | 12 |
View Market Depth
| Last trade - 14.30pm 23/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
-0.005 ( 1.23 %) |
||||
| Open | High | Low | Volume | ||
| 11.8¢ | 11.8¢ | 11.5¢ | 19348 | ||
| Last updated 14.30pm 23/05/2024 ? | |||||
| SPL (ASX) Chart |